Results 221 to 230 of about 80,496 (306)

EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation

HemaSphere, Volume 10, Issue 6, June 2026.
Abstract Previous editions of the European guidelines for the management of chronic lymphocytic leukemia (CLL) were developed by experts in CLL under the auspices of the European Society for Medical Oncology (ESMO). These previous editions have served as a reference text for many physicians caring for patients with CLL.
Barbara Eichhorst, Paolo Ghia, Francesc Bosch, Ruth Clifford, Michael Gregor, Romain Guieze, Arnon P. Kater, Carsten U. Niemann, Sarka Pospisilova, Tadeusz Robak, Anna Schuh, Kostas Stamatopoulos, Tamar Tadmor, Nick York   +13 more
wiley   +1 more source

From Jenner to genomics: the unfolding future of vaccinology. [PDF]

Front Immunol
Batool R.
europepmc   +1 more source

Traveling with chronic viral hepatitis. [PDF]

Trop Dis Travel Med Vaccines
Celik D, Silva CN, Santos L, Habibovic S, Corovic IF, Duduveche AE, Cinar G, Kucukkaya S, Khopkar-Kale P, Rawat SK, Gherlan GS, Rajan AK, Zerja A, Miron VD, ESCMID Study Group for Viral Hepatitis (ESGVH).   +14 more
europepmc   +1 more source

The Current Status of Simultaneous Vaccination of Children Aged 0-3 Years - China, 2022-2024. [PDF]

China CDC Wkly
Liu X, Liang Y, Zhang Z, Zhang S, Ye J, Hu R, Cao L, Peng H, Li L, Song Y, Yu W.   +10 more
europepmc   +1 more source

Vaccines at the Heart of Hepatitis Elimination: Insights From the ESCMID Study Group for Viral Hepatitis (ESGVH). [PDF]

Liver Int
Săndulescu O, Şahin GÖ, Dudman SG, Said ZNA, Mondelli MU, ESCMID Study Group for Viral Hepatitis (ESGVH).   +5 more
europepmc   +1 more source

From Plate to Patient: A Systematic Review of Food‐Related Campylobacteriosis Case Reports

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Campylobacteriosis, primarily caused by Campylobacter jejuni, C. coli, and C. fetus, remains the leading bacterial cause of foodborne gastroenteritis globally, with increasing incidence in both developed and developing nations.
Minoo Moghimani, Fateme Asadi Touranlou, Lida Jarahi, Asma Afshari   +3 more
wiley   +1 more source

Immunogenicity and safety of co-administered <i>Escherichia coli</i>-produced bivalent HPV-16/18 vaccine and hepatitis E vaccine. [PDF]

Front Immunol
Yan R, Cen M, Zhou Y, Ma L, Zhou X, He H, Qi X, Tang X, Liang H, Chen Y, Qi J, Yang S.   +11 more
europepmc   +1 more source

A Protocol of National Mixed‐Methods Assessment of Childhood and Maternal Immunization

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Accurate measurement of routine immunization coverage is essential for detecting immunity gaps, guiding programmatic responses, and supporting equitable vaccine delivery. Iran's Expanded Programme on Immunization has achieved high coverage, but administrative estimates can mask some disparities.
Seyed Aria Nejadghaderi, Paria Dehesh, Mehran Nakhaeizadeh, Mohammadreza Rajabalipour, Faeze Tahrudi, Naser Nasiri, Seyed Mohsen Zahraei, Hamid Sharifi, AliAkbar Haghdoost   +8 more
wiley   +1 more source

Antibody levels and immune memory in children with kaposiform hemangioendothelioma treated with sirolimus after catch up vaccination. [PDF]

Hum Vaccin Immunother
Yuan J, Ding Y, Wang Z, Su L, Li K.
europepmc   +1 more source

Hepatitis C Virus Infection in the PERSIAN Guilan Cohort Study Population: Intrafamilial Transmission Incidence and Response to SOVODAK‐Based Therapy

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background Hepatitis C virus (HCV) infection is one of the leading causes of liver‐related diseases such as cirrhosis and hepatocellular carcinoma. Despite ongoing efforts, no effective vaccine has been developed to date due to the virus's high mutation rate and extensive genetic variability. This study aimed to determine the prevalence of HCV
Farahnaz Joukar, Sara Yeganeh, Narges Eslami, Fariborz Mansour‐Ghanaei   +3 more
wiley   +1 more source